aspartic acid has been researched along with flurbiprofen in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Abdel-Aziz, AA; El-Kamel, AH; El-Subbagh, HI; Fatani, AJ | 1 |
| Barbato, G; Benarese, M; Blandini, F; Feligioni, M; Graziani, M; Imbimbo, BP; Lanzillotta, A; Mango, D; Mercuri, NB; Nicoletti, F; Nisticò, R; Panico, MB; Piccirilli, S; Pieraccini, S; Pizzi, M; Porrini, V; Schepisi, C; Sironi, M | 1 |
4 other study(ies) available for aspartic acid and flurbiprofen
| Article | Year |
|---|---|
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption | 2007 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Oral colon targeted delivery systems for treatment of inflammatory bowel diseases: synthesis, in vitro and in vivo assessment.
Topics: Acetic Acid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspartic Acid; Buffers; Chromatography, High Pressure Liquid; Colon; Cyclodextrins; Drug Carriers; Drug Delivery Systems; Flurbiprofen; Gastrointestinal Transit; Hydrogen-Ion Concentration; Hydrolysis; In Vitro Techniques; Inflammatory Bowel Diseases; Male; Naproxen; Prodrugs; Rats; Sulindac | 2008 |
Electrophysiological and metabolic effects of CHF5074 in the hippocampus: protection against in vitro ischemia.
Topics: Acetates; Alanine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspartic Acid; Cells, Cultured; Cyclopropanes; Electrophysiological Phenomena; Flurbiprofen; Hippocampus; In Vitro Techniques; Ischemia; Lactic Acid; Male; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; Rats, Wistar | 2014 |